Kopran's Q4 FY 2025-26 Quarterly Results

Result Summary

• Kopran Ltd reported a 20.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 33.3%.
• Its expenses for the quarter were up by 13.7% QoQ and 28.9% YoY.
• The net profit increased 102.0% QoQ and increased 94.9% YoY.
• The earnings per share (EPS) of Kopran Ltd stood at 3.91 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kopran Ltd is a company that operates within the pharmaceutical industry. It focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosages. Kopran Ltd is known for its commitment to innovation and quality in the healthcare sector. While specific recent developments about the company are not provided in the data, its ongoing operations in the pharmaceutical industry suggest it plays a significant role in the supply of essential medications and healthcare solutions.

Revenue

In the fourth quarter of the financial year 2026 (Q4FY26), Kopran Ltd reported total income of ₹234.11 crores, marking a 20.5% increase from the previous quarter (Q3FY26), where total income stood at ₹194.35 crores. Compared to the same quarter in the previous year (Q4FY25), the total income shows a growth of 33.3%, having been ₹175.62 crores. This upward trajectory in revenue suggests robust performance in terms of income generation, with significant year-over-year and quarter-over-quarter growth.

Profitability

Kopran Ltd's profit before tax (PBT) for Q4FY26 was ₹25.35 crores, a substantial rise from ₹10.74 crores in Q3FY26, representing a 136.0% increase. Year-over-year, PBT increased by 84.9% from ₹13.71 crores in Q4FY25. The tax expense for Q4FY26 was ₹6.48 crores, which is a significant increase from ₹1.40 crores in Q3FY26 and ₹4.03 crores in Q4FY25. The profit after tax (PAT) recorded for Q4FY26 was ₹18.87 crores, doubling from ₹9.34 crores in the previous quarter, marking a 102.0% increase, and a 94.9% increase from ₹9.68 crores in Q4FY25. The earnings per share (EPS) for Q4FY26 was ₹3.91, up from ₹1.93 in Q3FY26 and ₹2.01 in Q4FY25, showing a 102.6% quarter-over-quarter growth and a 94.5% year-over-year increase.

Operating Metrics

The total expenses for Kopran Ltd in Q4FY26 were ₹208.76 crores, which indicates a 13.7% increase from ₹183.61 crores in Q3FY26. Year-over-year, total expenses grew by 28.9% from ₹161.92 crores in Q4FY25. Although the expenses have increased, the growth in total income has outpaced the growth in expenses, contributing to improved profitability metrics. The significant increase in profit before tax and profit after tax, along with the rising earnings per share, reflect the company's effective management of its operational costs in relation to its income growth.